Why HCA Healthcare, Inc.’s (HCA) Stock Is Down 5.34%
As of Tuesday, October 27, HCA Healthcare, Inc.’s HCA share price has dipped by 5.34%, which has investors questioning if this is right time to buy.Jenna Brashear
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Rosalio Madrigal
Tudor Pop
Michael Rose
Michael Rose
| Share Statistics | HCA | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $98,845.8 | $1,847.0 | 97% |
|
| Shares Out (Mil) | 222.8 | 81.4 | 78% |
|
| Institutional Ownership | 97.8% | 85.8% | 75% |
|
| Float (Mil) | 144.3 | 57.1 | 68% |
|
| Beta | 1.11 | 0.75 | 66% |
|
| Avg Daily Volume (000s) | 1,422 | 673 | 76% |
|
| Price Change (52-week) |
1.0% | 80.0% | 53% |
|
| Growth | HCA | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 8.0% | 10.4% | 51% |
|
| Net Income (5yr) | 12.6% | (0.7%) | 59% |
|
| EPS (5yr) | 21.0% | 0.3% | 70 |
|
| Dividends (5yr) | 46.3% | 0.0% | 94% |
|
| Cash Flow (5yr) | (25.3%) | (17.4%) | 25% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 18 | 19 | 23 | |
| Current EPS | $8.188 | $30.107 | $31.284 | |
| Month Ago EPS | $8.048 | $29.489 | $32.016 | |
| # Rev Up | 2 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | $7.977 | $29.559 | $32.159 | |
| Year/Year Chg | 7.5% | 6.3% | 22.6% | |
| Financials | HCA | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $78,013 | $1,504 | 98% |
|
| Net Income (TTM) (Mil) | $6,840 | $31 | 97% |
|
| EPS (TTM) | $30.276 | $0.300 | 99% |
|
| Operating Cash Flow (TTM) (Mil) | $11,124 | $157 | 98% |
|
| Net Cash Flow (TTM) (Mil) | $74 | $2 | 74% |
|
| Long-Term Debt (Q1) (Mil) | $45,288 | $394 | 98% |
|
| Enterprise Value (Q1) (Mil) | $140,348 | $2,345 | 97% |
|
| Valuation | HCA | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.88 | na |
|
| P/E | 15.8 | 26.5 | 41% |
|
| Dividend Yield | 0.7% | 0.0% | 64% |
|
| PEG (5yr hist) | 0.8 | 1.0 | 37% |
|
| Ratios | HCA | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 42.8% | 27.0% | 53% |
|
| Net Margin | 8.6% | 1.3% | 58% |
|
| ROA | 11.1% | 2.1% | 88% |
|
| ROE | (124.0%) | 6.9% | 7% |
|
| Liabilities to Assets | 105.1% | 62.1% | 95% |
|
| F-Score | 8 | 5 | 93% |
|
Passing Stock Screens
As of 10/30/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 6.9% |
| +/- S&P 500: | -0.5 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors